With the analysis among 40 patents, we discovered top 19 key players by total patent application. Hospira, Inc., Diurnal Ltd., Sanofi-Aventis Deutschland GmbH are dominant in this area. They take 42.50% of the total patent filing.
Illinois, United States
Patent: 9
Illinois, United States
Patent: 1
Emilia-Romagna, Italy
Patent: 1
Massachusetts, United States
Patent: 1
Pennsylvania, United States
Patent: 1
Rheinland-Pfalz, Germany
Patent: 1
No data, please try another search term
With the analysis among related 14 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Agfa NV, China Sinopharm International Corp., Crohn's & Colitis Foundation of America take 28.57% of patent filing during this period.
China Sinopharm International Corp.
Beijing Shi, China
Patent: 1
Crohn's & Colitis Foundation of America
New York, United States
Patent: 1
undefined undefined
Patent: 1
undefined undefined
Patent: 1
Emilia-Romagna, Italy
Patent: 1
Shandong Sheng, China
Patent: 1
Massachusetts, United States
Patent: 1
Ohio, United States
Patent: 1
With the analysis among related 14 patents in last 5 years, we discover 8 new entrants. Agfa NV, China Sinopharm International Corp., Crohn's & Colitis Foundation of America are the most active new entrants in this area.
China Sinopharm International Corp.
Beijing Shi, China
Patent: 1
Crohn's & Colitis Foundation of America
New York, United States
Patent: 1
undefined undefined
Patent: 1
undefined undefined
Patent: 1
Emilia-Romagna, Italy
Patent: 1
Shandong Sheng, China
Patent: 1
Massachusetts, United States
Patent: 1
With the analysis among 17 patents, we discovered top 4 universities and scientific research institutions by total patent application. Kharkiv National Medical University, Odessa National Medical University, University of Sao Paulo are dominant in this area. They take 29.41% of the total patent filing.
São Paulo, Brazil
Patent: 1
Hubei Sheng, China
Patent: 1